{"id":29727,"date":"2021-12-15T16:33:36","date_gmt":"2021-12-15T14:33:36","guid":{"rendered":"https:\/\/aluksne.lv\/?p=29727"},"modified":"2021-12-15T16:33:36","modified_gmt":"2021-12-15T14:33:36","slug":"sakas-bernu-vecuma-no-5-11-gadiem-vakcinacija-pret-covid-19","status":"publish","type":"post","link":"https:\/\/aluksne.lv\/index.php\/2021\/12\/15\/sakas-bernu-vecuma-no-5-11-gadiem-vakcinacija-pret-covid-19\/","title":{"rendered":"S\u0101kas b\u0113rnu vecum\u0101 no 5-11 gadiem vakcin\u0101cija pret Covid-19"},"content":{"rendered":"

\"\"<\/a>No r\u012btdienas, 16.decembra, vakc\u012bnu pret Covid-19 var sa\u0146emt ikviens b\u0113rns no piecu gadu vecuma, ta\u010du vakcin\u0101cija \u012bpa\u0161i ieteicama ir b\u0113rniem ar da\u017e\u0101d\u0101m hronisk\u0101m saslim\u0161an\u0101m, piem\u0113ram, ar virssvaru, cukura diab\u0113tu, smagiem im\u016bnsist\u0113mas trauc\u0113jumiem, hronisk\u0101m kardiovaskul\u0101raj\u0101m un nieru slim\u012bb\u0101m, k\u0101 ar\u012b onkolo\u0123isk\u0101m saslim\u0161an\u0101m, \u0161odien preses konferenc\u0113 inform\u0113ja Imuniz\u0101cijas valsts padomes priek\u0161s\u0113d\u0113t\u0101ja, asoc. prof. Dr. med. Dace Zavadska. <\/strong><\/p>\n

\u00a0<\/strong><\/p>\n

B\u0113rniem ar hronisk\u0101m saslim\u0161an\u0101m \u00a0l\u012bdz\u012bgi k\u0101 pieaugu\u0161ajiem, ir augst\u0101ks risks nopietn\u0101k saslimt ar Covid-19. Riskus, saslimstot ar Covid-19, b\u0113rniem rada ne tikai blakus saslim\u0161anas. Latvij\u0101 nov\u0113roti ar\u012b gad\u012bjumi, kad b\u0113rniem da\u017e\u0101s ned\u0113\u013c\u0101s p\u0113c Covid-19 izslimo\u0161anas att\u012bst\u012bjies pediatriskais multisist\u0113mu iekaisuma sindroms ar ilgsto\u0161i paaugstin\u0101tu temperat\u016bru, acu aps\u0101rtumu, ku\u0146\u0123a, sirds un asinsvadu sist\u0113mas trauc\u0113jumiem un cit\u0101m izpausm\u0113m, uzsver profesore Zavadska.<\/p>\n

 <\/p>\n

\u201cTie\u0161i riska grup\u0101s eso\u0161o b\u0113rnu vec\u0101ki ir vieni no tiem, kuri vakc\u012bnu papildu dro\u0161\u012bbai c\u012b\u0146\u0101 ar Covid-19 ir gaid\u012bju\u0161i visvair\u0101k. T\u0101pat par b\u0113rnu vakcin\u0101ciju akt\u012bvi interes\u0113jas t\u0101s mammas un t\u0113ti, kuru b\u0113rni ir vecuma grup\u0101 9 l\u012bdz 11 gadi – \u00a0\u0161o nodro\u0161in\u0101jumu v\u0113las, lai mazin\u0101tu ierobe\u017eojumus\u00a0 ierastajam dz\u012bves ritmam. K\u0101 zin\u0101ms, p\u0113t\u012bjumi apliecina, ka ilgsto\u0161a m\u0101js\u0113de un ierobe\u017eojumi negat\u012bvi ietekm\u0113 b\u0113rnu un jaunie\u0161u soci\u0101l\u0101s aktivit\u0101tes un, attiec\u012bgi, ar\u012b vi\u0146u ment\u0101lo st\u0101vokli,\u201d atkl\u0101j vec\u0101ku organiz\u0101cijas “Mammamuntetiem.lv” vad\u012bt\u0101ja Inga Akmenti\u0146a-Smildzi\u0146a.<\/p>\n

 <\/p>\n

\u201cLatvija ir rea\u0123\u0113jusi \u0101tri un veikusi visus nepiecie\u0161amos pas\u0101kumus, lai veiksm\u012bgi uzs\u0101ktu b\u0113rnu vecum\u0101 no pieciem l\u012bdz 11 gadiem vakcin\u0101ciju, esam \u012bs\u0101 laik\u0101 nodro\u0161in\u0101ju\u0161i gan vakc\u012bnu pieejam\u012bbu, gan procesa organiz\u0101ciju,\u201d inform\u0113ja Nacion\u0101l\u0101 vesel\u012bbas dienesta Vakcin\u0101cijas projekta noda\u013cas vad\u012bt\u0101ja Eva Juh\u0146\u0113vi\u010da.<\/p>\n

 <\/p>\n

B\u0113rnu vecum\u0101 no pieciem l\u012bdz 11 gadiem vakcin\u0101cija notiek<\/strong> pie \u0123imenes \u0101rstiem un \u0101rstniec\u012bbas iest\u0101d\u0113s (polikl\u012bnik\u0101s, vesel\u012bbas centros un slimn\u012bc\u0101s). Pieteikt<\/strong> b\u0113rnu vakc\u012bnai var vec\u0101ki vai likumiskie p\u0101rst\u0101vji pie sava \u0123imenes \u0101rsta, \u0101rstniec\u012bbas iest\u0101d\u0113, k\u0101 ar\u012b \u00a0zvanot 8989. Pirms tam aicin\u0101m p\u0101rliecin\u0101ties, vai \u0123imenes \u0101rsta praks\u0113 vai \u0101rstniec\u012bbas iest\u0101d\u0113 ir pieejama Pfizer-BioNTech<\/em> b\u0113rnu vakc\u012bna Comirnaty. <\/em>Par to p\u0101rliecin\u0101ties var \u0161eit: https:\/\/www.vmnvd.gov.lv\/lv\/bernu-vakcinacija<\/a>.<\/p>\n

 <\/p>\n

Vakcin\u0101cija notiek vec\u0101ka vai cita likumisk\u0101 p\u0101rst\u0101vja kl\u0101tb\u016btn\u0113. L\u012bdzi j\u0101\u0146em \u0161\u0101di dokumenti: b\u0113rnam \u2013 pase vai personas apliec\u012bba (ja ir), vec\u0101kiem vai likumiskajam p\u0101rst\u0101vim – pase vai personas apliec\u012bba, k\u0101 ar\u012b apliecino\u0161s dokuments par b\u0113rnu – ieraksts par b\u0113rnu pas\u0113 vai dzim\u0161anas apliec\u012bba, vai nepiecie\u0161am\u012bbas gad\u012bjum\u0101 notari\u0101li apstiprin\u0101ta pilnvara.<\/p>\n

\u201cVakcin\u0113jot b\u0113rnus pie \u0123imenes \u0101rsta vai \u0101rstniec\u012bbas iest\u0101d\u0113, vec\u0101kiem t\u0101 ir ierasta vide, kur\u0101 regul\u0101ri notiek gan b\u0113rnu apskate, gan veiktas vakcin\u0101cijas kalend\u0101ra manipul\u0101cijas, ar\u012b \u0123imenes \u0101rsti lab\u0101k p\u0101rzina savu mazo pacientu vesel\u012bbu un vec\u0101ki var\u0113s uzdot visus interes\u0113jo\u0161os jaut\u0101jumus,\u201d skaidroja Juh\u0146\u0113vi\u010da.<\/p>\n

 <\/p>\n

Speci\u0101listi nor\u0101da, ka b\u0113rniem, at\u0161\u0137ir\u012bb\u0101 no pieaugu\u0161ajiem, tiek rekomend\u0113ts ilg\u0101ks starplaiks<\/strong> starp 1. un 2. vakc\u012bnas devas sa\u0146em\u0161anu –\u00a0 b\u0113rniem tie ir 3 m\u0113ne\u0161i. Ja b\u0113rnam k\u0101du iemeslu d\u0113\u013c ir nepiecie\u0161ams sa\u0146emt otro devu \u0101tr\u0101k par noteikto laiku, tas ir pie\u013caujams, saska\u0146\u0101 ar vakc\u012bnas re\u0123istr\u0101ciju (re\u0123istr\u0113tais interv\u0101ls starp 1. un 2. devas lieto\u0161anu ir 21 diena).<\/p>\n

Vakcin\u0101cijas sertifik\u0101ts b\u0113rniem vecum\u0101 no 5 l\u012bdz 11 gadiem<\/strong> b\u016bs izmantojams 15.dien\u0101 p\u0113c vakc\u012bnas otr\u0101s devas sa\u0146em\u0161anas. To b\u0113rna vec\u0101ki vai likumiskais p\u0101rst\u0101vis var\u0113s lejupiel\u0101d\u0113t vietn\u0113 https:\/\/covid19sertifikats.lv\/<\/a>.<\/p>\n

K\u0101 jebkuriem citiem medikamentiem, ar\u012b katrai Covid-19 vakc\u012bnai, tostarp ar\u012b b\u0113rniem paredz\u0113tajai, pirms izmanto\u0161anas Eiropas Savien\u012bb\u0101 j\u0101atbilst stingr\u0101m kvalit\u0101tes, dro\u0161uma un efektivit\u0101tes pier\u0101d\u012bjumu pras\u012bb\u0101m. Gan pieaugu\u0161o, gan b\u0113rnu vakc\u012bnas pret Covid-19 ir dro\u0161as, p\u0101rbaud\u012btas un stiprina imunit\u0101ti c\u012b\u0146\u0101 ar kovidu.<\/p>\n

Jaut\u0101jumi un atbildes par b\u0113rnu vakcin\u0101ciju<\/p>\n

<\/strong><\/h2>\n

    \n
  1. Vai vakc\u012bna pien\u0101kas visiem b\u0113rniem?<\/strong><\/li>\n<\/ol>\n

    Balstoties uz PVO un EZA public\u0113tajiem p\u0113t\u012bjumiem un ar m\u0113r\u0137i stiprin\u0101t imunit\u0101ti, un mazin\u0101t saslim\u0161anas riskus, vakc\u012bnu var sa\u0146emt ikviens b\u0113rns, kur\u0161 ir vismaz 5 gadus vecs.<\/p>\n

      \n
    1. Ar ko at\u0161\u0137iras b\u0113rnu un pieaugo\u0161o vakc\u012bna?<\/strong><\/li>\n<\/ol>\n

      B\u0113rniem vecum\u0101 no 5 l\u012bdz 11 gadiem vakcin\u0101cijai pret Covid-19 tiek izmantota Comirnaty 10 \u00b5g (mikrogramu) vakc\u012bna, savuk\u0101rt b\u0113rniem no 12 gadu vecuma un pieaugu\u0161ajiem devas lielums vakc\u012bnai Comirnaty ir 30 \u00b5g (mikrogrami). B\u0113rnu vakc\u012bna at\u0161\u0137iras\u00a0 p\u0113c devas lieluma, tas ir tr\u012bs reizes maz\u0101ks un lai atvieglotu medic\u012bnas person\u0101la ikdienas darbu, mar\u0137\u0113ta ar oran\u017eu v\u0101ci\u0146u.<\/p>\n

        \n
      1. K\u0101 varu pieteikt b\u0113rnu vakcin\u0101cijai?<\/strong><\/li>\n<\/ol>\n

        B\u0113rnu vakcin\u0101cija notiek pie \u0123imenes \u0101rstiem un \u0101rstniec\u012bbas iest\u0101d\u0113s. Pieteikt b\u0113rnu var m\u0101te, t\u0113vs vai likumiskais p\u0101rst\u0101vis, sazinoties ar\u00a0 \u0123imenes \u0101rstu, \u0101rstniec\u012bbas iest\u0101di, vai zvanot uz t\u0101lruni 8989. Aicin\u0101m iepriek\u0161 p\u0101rliecin\u0101ties, ka vakcin\u0101cijas punkt\u0101 ir pieejamas Pfizer-BioNTech<\/em> b\u0113rnu vakc\u012bna Comirnaty<\/em>. Aktu\u0101l\u0101 inform\u0101cija par vakcin\u0101cijas kabinetiem, kuros ir pieejamas Pfizer-BioNTech<\/em> b\u0113rnu vakc\u012bnas Comirnaty<\/em> ir atrodama https:\/\/www.vmnvd.gov.lv\/lv\/bernu-vakcinacija<\/a>.<\/p>\n

        Vakcin\u0101cija notiek vec\u0101ka vai cita likumisk\u0101 p\u0101rst\u0101vja kl\u0101tb\u016btn\u0113. L\u012bdzi j\u0101\u0146em \u0161\u0101di dokumenti: b\u0113rnam \u2013 pase vai personas apliec\u012bba (ja ir), vec\u0101kiem vai likumiskajam p\u0101rst\u0101vim – pase vai personas apliec\u012bba, k\u0101 ar\u012b apliecino\u0161s dokuments par b\u0113rnu – ieraksts par b\u0113rnu pas\u0113 vai dzim\u0161anas apliec\u012bba, vai nepiecie\u0161am\u012bbas gad\u012bjum\u0101 notari\u0101li apstiprin\u0101ta pilnvara.<\/p>\n

          \n
        1. Kur notiek b\u0113rnu vakcin\u0101cija?<\/strong><\/li>\n<\/ol>\n

          5 \u2013 11 gadus vecu b\u0113rnu vakcin\u0101cijai izv\u0113l\u0113tas \u0123imenes \u0101rstu prakses un \u0101rstniec\u012bbas iest\u0101des. Pirms pieteik\u0161an\u0101s aicin\u0101m p\u0101rliecin\u0101ties, ka vakcin\u0101cijas punkt\u0101 ir b\u0113rniem paredz\u0113t\u0101 vakc\u012bna.<\/p>\n

            \n
          1. Vai vakcin\u0113t b\u0113rnu pret Covid-19, ja vi\u0146am ir smagas hroniskas saslim\u0161anas?<\/strong><\/li>\n<\/ol>\n

            Vakcin\u0101cija priorit\u0101ri ir nepiecie\u0161ama b\u0113rniem ar jau eso\u0161iem vesel\u012bbas trauc\u0113jumiem \u2013 onkolo\u0123isk\u0101m saslim\u0161an\u0101m, virssvaru, cukura diab\u0113tu, kardiovaskul\u0101r\u0101m fona saslim\u0161an\u0101m un cit\u0101m hronisk\u0101m slim\u012bb\u0101m.<\/p>\n

              \n
            1. Kur v\u0113rsties, ja rodas \u0161aubas par vakcin\u0101ciju?<\/strong><\/li>\n<\/ol>\n

              Ja rodas k\u0101das \u0161aubas vai ja b\u0113rnam ir, piem\u0113ram, k\u0101das hroniskas saslim\u0161anas, tad pirms vakc\u012bnas sa\u0146em\u0161anas aicin\u0101m pieteikt viz\u012bti pie \u0123imenes \u0101rsta vai \u0101rst\u0113jo\u0161\u0101 \u0101rsta, lai p\u0101rrun\u0101tu b\u0113rna individu\u0101lo vesel\u012bbu un ar to saist\u012btos jaut\u0101jumus.<\/p>\n

                \n
              1. Kad b\u0113rni var\u0113s sa\u0146emt 2.vakc\u012bnas devu?<\/strong><\/li>\n<\/ol>\n

                B\u0113rniem, at\u0161\u0137ir\u012bb\u0101 no pieaugu\u0161ajiem, tiek rekomend\u0113ts ilg\u0101ks starplaiks starp 1. un 2. vakc\u012bnas devas sa\u0146em\u0161anu – \u00a0b\u0113rniem tie ir 3 m\u0113ne\u0161i. Ja b\u0113rnam k\u0101du iemeslu d\u0113\u013c ir nepiecie\u0161ams sa\u0146emt otro devu \u0101tr\u0101k par noteikto laiku, tas ir pie\u013caujams, \u00a0saska\u0146\u0101 ar vakc\u012bnas re\u0123istr\u0101ciju (re\u0123istr\u0113tais interv\u0101ls starp 1. un 2. devas lieto\u0161anu ir 21 diena).<\/p>\n

                  \n
                1. Manam b\u0113rnam t\u016bl\u012bt b\u016bs 12 gadi, kura vakc\u012bnas deva vi\u0146am ir j\u0101sa\u0146em?<\/strong><\/li>\n<\/ol>\n

                  Devas lielums tiek balst\u012bts uz b\u0113rna vecumu pirm\u0101s devas vakcin\u0101cijas dien\u0101. Ja b\u0113rnam gadi no 11 uz 12 main\u0101s laik\u0101 no pirm\u0101s l\u012bdz otr\u0101s devas sa\u0146em\u0161anai, tad gan k\u0101 pirm\u0101, gan otr\u0101 deva tiek sa\u0146emta b\u0113rna vakc\u012bnas deva.<\/p>\n

                    \n
                  1. Vai var vakcin\u0113t b\u0113rnu pret Covid-19, ja nesen sa\u0146emta cita vakc\u012bna?<\/strong><\/li>\n<\/ol>\n

                    Covid-19 vakc\u012bnas gan b\u0113rniem, gan pieaugu\u0161ajiem var ievad\u012bt vienlaic\u012bgi ar cit\u0101m vakc\u012bn\u0101m, taj\u0101 pa\u0161\u0101 dien\u0101 vai jebk\u0101d\u0101 interv\u0101l\u0101 pirms un p\u0113c Covid-19 vakc\u012bnas sa\u0146em\u0161anas.<\/p>\n

                      \n
                    1. Vai b\u0113rnu ir nepiecie\u0161ams vakcin\u0113t, ja ir p\u0101rslimots Covid-19?<\/strong><\/li>\n<\/ol>\n

                      Lai nodro\u0161in\u0101tu maksim\u0101lu aizsardz\u012bbu pret Covid-19, ar\u012b b\u0113rniem, kuri ir p\u0101rslimoju\u0161i Covid-19 (ko apliecina pozit\u012bvs PCR testa rezult\u0101ts medic\u012bniskaj\u0101 dokument\u0101cij\u0101), ir j\u0101vakcin\u0113jas. \u0160\u0101d\u0101 gad\u012bjum\u0101 pietiek ar vienu vakc\u012bnas devu.<\/p>\n

                        \n
                      1. K\u0101p\u0113c b\u0113rniem starp ab\u0101m vakc\u012bnu dev\u0101m ir tik gar\u0161 laika interv\u0101ls?<\/strong><\/li>\n<\/ol>\n

                        B\u0113rniem vecum\u0101 no 5 l\u012bdz 11 gadiem individu\u0101l\u0101s aizsardz\u012bbas sp\u0113ja p\u0113c vienas sa\u0146emtas mRNS vakc\u012bnas devas uzskat\u0101ma par b\u016btisku un \u012bslaic\u012bgi pietiekamu, lai nov\u0113rstu vid\u0113ji smagu, smagu saslim\u0161anas gaitu un hospitaliz\u0101cijas nepiecie\u0161am\u012bbu. Pamatojoties uz p\u0113t\u012bjumiem un citu valstu pieredz\u0113 balst\u012bto inform\u0101ciju, ar\u012b viena deva sniedz iev\u0113rojamu efektivit\u0101ti gan asimptom\u0101tiskas, gan vieglas gaitas nov\u0113r\u0161anai. Pirm\u0101s devas rad\u012bt\u0101 aizsardz\u012bba par optim\u0101lu ir uzskat\u0101ma 14 dienas p\u0113c vakc\u012bnas ievades.<\/p>\n

                          \n
                        1. K\u0101das organisma reakcijas var b\u016bt b\u0113rniem p\u0113c vakc\u012bnas?<\/strong><\/li>\n<\/ol>\n

                          B\u0113rniem p\u0113c vakc\u012bnas sa\u0146em\u0161anas var b\u016bt t\u0101das pa\u0161as reakcijas k\u0101 pieaugu\u0161ajiem \u2013 aps\u0101rtums, piet\u016bkums vai s\u0101pes injekcijas viet\u0101, drudzis, nogurums, slikta pa\u0161saj\u016bta, reibonis, galvass\u0101pes, slikta d\u016b\u0161a, vem\u0161ana. \u0160ie simptomi izz\u016bd da\u017eu dienu laik\u0101 (1-3 dien\u0101s) un \u0101rst\u0113\u0161ana nav nepiecie\u0161ama.<\/p>\n

                            \n
                          1. Ko dar\u012bt, ja simptomi saglab\u0101jas ilg\u0101k k\u0101 3 dienas?<\/strong><\/li>\n<\/ol>\n

                            Ja paman\u0101t, ka simptomi p\u0113c vakc\u012bnas sa\u0146em\u0161anas nepaz\u016bd tr\u012bs dienu laik\u0101, l\u016bdzu, sazinieties ar savu \u0123imenes \u0101rstu.<\/p>\n

                              \n
                            1. Kas garant\u0113 vakc\u012bnas dro\u0161umu?<\/strong><\/li>\n<\/ol>\n

                              Ikvienai Covid-19 vakc\u012bnai, taj\u0101 skait\u0101 ar\u012b b\u0113rniem paredz\u0113tajai vakc\u012bnai, ko izmanto Eiropas Savien\u012bb\u0101, pirms tam ir j\u0101izpilda stingras kvalit\u0101tes, dro\u0161uma un efektivit\u0101tes pier\u0101d\u012bjumu pras\u012bbas, tie\u0161i t\u0101pat k\u0101 jebkuriem citiem medikamentiem. Nek\u0101das atk\u0101pes no \u0161\u012bm pamatpras\u012bb\u0101m nav iesp\u0113jamas. Gan b\u0113rniem, gan pieaugu\u0161ajiem izmantot\u0101 vakc\u012bna ir dro\u0161a un p\u0101rbaud\u012bta.<\/p>\n

                                \n
                              1. Kad un k\u0101 b\u0113rni ieg\u016bs sertifik\u0101tus?<\/strong><\/li>\n<\/ol>\n

                                Vakcin\u0101cijas sertifik\u0101ts b\u0113rniem vecum\u0101 no 5 l\u012bdz 11 gadiem b\u016bs izmantojams 15.dien\u0101 p\u0113c vakc\u012bnas otr\u0101s devas sa\u0146em\u0161anas. To b\u0113rna vec\u0101ki vai likumiskais p\u0101rst\u0101vis var\u0113s lejupiel\u0101d\u0113t vietn\u0113 https:\/\/covid19sertifikats.lv\/<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"

                                No r\u012btdienas, 16.decembra, vakc\u012bnu pret Covid-19 var sa\u0146emt ikviens b\u0113rns no piecu gadu vecuma, ta\u010du vakcin\u0101cija \u012bpa\u0161i ieteicama ir b\u0113rniem ar da\u017e\u0101d\u0101m hronisk\u0101m saslim\u0161an\u0101m, piem\u0113ram, ar virssvaru, cukura diab\u0113tu, smagiem im\u016bnsist\u0113mas trauc\u0113jumiem, hronisk\u0101m kardiovaskul\u0101raj\u0101m un nieru slim\u012bb\u0101m, k\u0101 ar\u012b onkolo\u0123isk\u0101m…
                                Las\u012bt visu<\/a><\/p>\n","protected":false},"author":1,"featured_media":29728,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_crdt_document":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[9],"tags":[],"class_list":["post-29727","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noderiga-informacija"],"_links":{"self":[{"href":"https:\/\/aluksne.lv\/index.php\/wp-json\/wp\/v2\/posts\/29727","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aluksne.lv\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/aluksne.lv\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/aluksne.lv\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/aluksne.lv\/index.php\/wp-json\/wp\/v2\/comments?post=29727"}],"version-history":[{"count":0,"href":"https:\/\/aluksne.lv\/index.php\/wp-json\/wp\/v2\/posts\/29727\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/aluksne.lv\/index.php\/wp-json\/wp\/v2\/media\/29728"}],"wp:attachment":[{"href":"https:\/\/aluksne.lv\/index.php\/wp-json\/wp\/v2\/media?parent=29727"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/aluksne.lv\/index.php\/wp-json\/wp\/v2\/categories?post=29727"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/aluksne.lv\/index.php\/wp-json\/wp\/v2\/tags?post=29727"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}